(Q33730581)

29 July 2017

1 reference

title

Clinical use of aromatase inhibitors: current data and future perspectives (English)

1 reference

29 July 2017

Santen RJ

1

1 reference

29 July 2017

1 January 1990

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

29 July 2017

1 reference

29 July 2017

4

1 reference

29 July 2017

2

1 reference

29 July 2017

79-99

1 reference

Regulation of estrogen biosynthesis by human adipose cells

29 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

The nature of the final oxidative step in the aromatization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Concerning the pathway from 19-oxoandrost-4-ene-3,17-dione to estrone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Estrone and estradiol content in human breast tumors: Relationship to estradiol receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aromatization of androgens by human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Effects of aminoglutethimide on adrenal steroid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Treatment of breast cancer with aromatase inhibitors--current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Potency and specificity of CGS-16949A as an aromatase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Inhibition of aromatase with CGS 16949A in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide: a "side-effect" turned to therapeutic advantage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Modifiers of steroid-hormone metabolism: a review of their chemistry, biochemistry and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide: review of pharmacology and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Compensatory Increase in TSH Secretion without Effect on Prolactin Secretion in Patients Treated with Aminoglutethimide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Aminoglutethimide in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756369009040730

10.3109/14756369009040730

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

2098526